Integral Biosystems, LLC
Bioengineered sustained-release ocular implant delivering Travoprost via biodegradable mucoadhesive polymers
- Sector
- Medtech
- Total capital
- $241K
- Federal grants
- $241K
- 1 award · 2015
- Rank in peer group#265 of 542
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 4 pending · first 2018
- Rank in peer group#47 of 542
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Development of a Novel, Non-invasive, Self-Administered, Preservative-Free, Biodegradable, Sustained Release Product for Glaucoma Therapy.$241K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 542 peers
Line = medianMedtech · Device
- Federal grants#265 · top 49%
- Granted patents#47 · top 9%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 4 granted of 8- GrantedMembrane-adherent Self-assembled Systems For Treatment Of Ocular DisordersUSPTOUS 10,603,273
- GrantedMethods And Biocompatible Compositions To Achieve Sustained Drug Release In The EyeUSPTOUS 10,328,033
- GrantedMethods And Biocompatible Compositions To Achieve Sustained Drug Release In The EyeUSPTOUS 9,931,306
Show all 8 patent records
- Membrane-adherent Self-assembled Systems For Treatment Of Ocular DisordersMar 31, 2020 · US 10,603,273Granted
- Methods And Biocompatible Compositions To Achieve Sustained Drug Release In The EyeJun 25, 2019 · US 10,328,033Granted
- Methods And Biocompatible Compositions To Achieve Sustained Drug Release In The EyeApr 3, 2018 · US 9,931,306Granted
- Membrane-adherent Self-assembled Systems For Treatment Of Ocular DisordersFeb 27, 2018 · US 9,901,544Granted
- Membrane-adherent Self-assembled Systems For Treatment Of Ocular DisordersApplication PCTUS2015028748Pending
- Methods And Compositions To Administer Therapeutics To Soft Tissue SurfacesApplication 63551400Pending
- Methods And Biocompatible Compositions To Achieve Sustained Drug Release In The EyeApplication PCTUS2015048795Pending
- Methods And Compositions To Administer Therapeutics To Soft Tissue SurfacesApplication PCTUS2025014512Pending
Related companies, and why
- Birkeland Current LLCSimilar federal contract value in Medtech · null in contracts
- LAYERBIO INCSimilar federal contract value in Medtech · null in contracts
- Hura Imaging, Inc.Similar federal contract value in Medtech · null in contracts
- COHERE-MED, INC.Similar federal contract value in Medtech · null in contracts
- Purist IncSimilar federal contract value in Medtech · null in contracts
- BREONICS, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .